Treatment Registry
TR-0680 ActiveRecorded September 2, 2026Last verified September 3, 2026

Compounded tirzepatide

Sold by PlexusDx · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$289

Medication · Tirzepatide Injection, month-to-month$289

Added from the figures recorded below.

Price

TermPer monthCharged today
Tirzepatide Injection, month-to-month

$289/mo month-to-month, $269/mo on the 3-month plan, and $249/mo on the 6-month plan

source, read September 2, 2026

Per month$289Charged today$289
Tirzepatide Injection, 6-month plan

$289/mo month-to-month, $269/mo on the 3-month plan, and $249/mo on the 6-month plan

source, read September 2, 2026

Per month$249Charged today$1,494
Visit PlexusDx

We earn nothing from this link. PlexusDx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

  1. September 2, 2026$289
  2. September 3, 2026$289
  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyBelmar Pharmacy; Strive Pharmacy; Epiq Scripts; Casa Pharma Rx; The Pharmacy Hub; Foothills Pharmacy
StatesAll 50 states
PrescriberBoth
Cancellation“Cancel anytime with no fees.”

Not yet checked: membership and consult fee.

Recorded from plexusdx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Every product page explicitly states 'No membership fee' / 'No membership, no hidden fees.' An optional $99 Precision Peptide Genetic Test add-on exists post-enrollment but is optional, not required, so it is not recorded as a membership.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0680
Readings
2

Related records

What else PlexusDx sells

All PlexusDx programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). PlexusDx compounded tirzepatide (TR-0680). Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0680

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.